Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease

被引：49
作者：
Kingwell, Bronwyn A. [1 ]
Chapman, M. John [2 ]
机构：
[1] Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia
[2] Pitie Salpetriere Univ Hosp, INSERM, UMRS 939, Dyslipidemia & Atherosclerosis Res Unit, Paris, France
来源：
CIRCULATION | 2013年 / 128卷 / 10期
基金：
英国医学研究理事会;
关键词：
acute coronary syndrome; apolipoproteins; atherosclerosis; cerebrovascular disorders; lipoproteins; HDL; peripheral arterial disease; therapy; ACUTE CORONARY SYNDROMES; REVERSE CHOLESTEROL TRANSPORT; RESTORES ENDOTHELIAL FUNCTION; APOA-I; HDL CHOLESTEROL; ATHEROSCLEROSIS REGRESSION; EFFLUX CAPACITY; GLUCOSE; OUTCOMES; STATINS;
D O I：
10.1161/CIRCULATIONAHA.113.002683
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1112 / 1121
页数：10
相关论文
共 73 条
  • [1] [Anonymous], CIRCULATION
  • [2] Acute Coronary Events
    Arbab-Zadeh, Armin
    Nakano, Masataka
    Virmani, Renu
    Fuster, Valentin
    [J]. CIRCULATION, 2012, 125 (09) : 1147 - 1156
  • [3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [4] BARTER P, 2011, AIM HIGH FALLOUT EXP
  • [5] HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
    Barter, Philip
    Gotto, Antonio M.
    LaRosa, John C.
    Maroni, Jaman
    Szarek, Michael
    Grundy, Scott M.
    Kastelein, John J. P.
    Bittner, Vera
    Fruchart, Jean-Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) : 1301 - 1310
  • [6] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [7] Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
    Barter, Philip J.
    Rye, Kerry-Anne
    Tardif, Jean-Claude
    Waters, David D.
    Boekholdt, S. Matthijs
    Breazna, Andrei
    Kastelein, John J. P.
    [J]. CIRCULATION, 2011, 124 (05) : 555 - 562
  • [8] Systematic Review of CETP Inhibitors for Increasing High-Density Lipoprotein Cholesterol: Where Do These Agents Stand in the Approval Process?
    Bishop, Bryan M.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (02) : 147 - 158
  • [9] Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein
    Bisoendial, RJ
    Hovingh, GK
    Levels, JHM
    Lerch, PG
    Andresen, I
    Hayden, MR
    Kastelein, JJP
    Stroes, ESG
    [J]. CIRCULATION, 2003, 107 (23) : 2944 - 2948
  • [10] Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
    Boden, William E.
    Probstfield, Jeffrey L.
    Anderson, Todd
    Chaitman, Bernard R.
    Desvignes-Nickens, Patrice
    Koprowicz, Kent
    McBride, Ruth
    Teo, Koon
    Weintraub, William
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) : 2255 - 2267
12345678